The role of in vitro diagnostics in early detection and treatment of cancer

Special focus dialogue

Cancer is the second leading cause of mortality globally. Early detection and access to effective cancer treatment can result in higher rates of survival and a better quality of life. However, patients in low-and middle-income countries (LMICs) are often diagnosed at a late disease stage, contributing to higher cancer mortality.

In vitro diagnostics (IVDs) provide essential data for screening, diagnosis and treatment. Access to IVDs is vital for the early detection of cancer, however in many LMICs access to quality assured medical diagnostics is not a given. Major challenges to the availability of IVDs include patient access, regulations, quality, supply chain, physical and personnel infrastructure, and costs. However, solutions are available depending on local context, political will, and resource allocation.

In this context, the Union for International Cancer Control (UICC), in collaboration with the American Society for Clinical Pathology (ASCP) and FIND, has launched a report on “The role of in vitro diagnostics in early detection and treatment of cancer”. The report highlights the role of in vitro diagnostics in early detection of disease, explores the barriers to accessing IVDs, particularly in LMICs, and outlines ways to address them.

Beatrice Vetter, Scientific Officer, FIND, will be part of this special focus dialogue on Monday 12 July, 14:00-15:00 CEST.

Register here